Arginine supplementation is safe for HIV/AIDS patients

A pilot study of the safety and efficacy of supplemental arginine to enhance immune function in persons with HIV/AIDS

This study evaluated the safety and efficacy of supplemental arginine in persons with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). 11 HIV-infected adults received either arginine or a placebo for 14 days. The results showed that short-term arginine supplementation is safe for persons with HIV/AIDS. Further details can be found in the study.
Barbara Swanson, Joyce K Keithley, Janice M Zeller, Beverly E Sha. A pilot study of the safety and efficacy of supplemental arginine to enhance immune function in persons with HIV/AIDS. Nutrition July–August, 2002. Volume 18, Issues 7-8, Pages 688–690


Leave a Reply